Spindle Cell Rhabdomyosarcoma disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

MCID: SPN009 MIFTS: 32	Spindle Cell Rhabdomyosarcoma Categories: Cancer diseases, Muscle diseases
Genes Variations Tissues Related diseases Publications Pathways Drugs Download Expand all tables

Sources

Aliases & Classifications for Spindle Cell Rhabdomyosarcoma

MalaCards integrated aliases for Spindle Cell Rhabdomyosarcoma:

Name: Spindle Cell Rhabdomyosarcoma ¹² ¹⁵ ⁷³

Classifications:

MalaCards categories:
Global: Cancer diseases
Anatomical: Muscle diseases

See all MalaCards categories (disease lists)

External Ids:

Disease Ontology ¹² DOID:3260

NCIt ⁵⁰ C6519

SNOMED-CT ⁶⁸ 128749008 404055006

UMLS ⁷³ C1266134

Sources

Summaries for Spindle Cell Rhabdomyosarcoma

MalaCards based summary : Spindle Cell Rhabdomyosarcoma is related to embryonal rhabdomyosarcoma and rhabdomyosarcoma. An important gene associated with Spindle Cell Rhabdomyosarcoma is MYOD1 (Myogenic Differentiation 1), and among its related pathways/superpathways are Neural Stem Cell Differentiation Pathways and Lineage-specific Markers and Regulation of nuclear SMAD2/3 signaling. The drugs Cyclophosphamide and Dactinomycin have been mentioned in the context of this disorder. Affiliated tissues include tongue, prostate and bone.

Wikipedia : ⁷⁶ Spindle cell rhabdomyosarcoma is a subtype of embryonal rhabdomyosarcoma first described by Cavazzana,... more...

Sources

Related Diseases for Spindle Cell Rhabdomyosarcoma

Diseases related to Spindle Cell Rhabdomyosarcoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 128)

#	Related Disease	Score	Top Affiliating Genes
1	embryonal rhabdomyosarcoma	32.3	DES MB MYOD1
2	rhabdomyosarcoma	30.9	DES MB MYOD1
3	cervical polyp	10.6	DES MYOD1
4	gallbladder sarcoma	10.6	DES MYOD1
5	inflammatory leiomyosarcoma	10.6	DES MYOD1
6	horner's syndrome	10.6	DES MYOD1
7	malignant fibrous histiocytoma of bone	10.6	DES MYOD1
8	giant cell myocarditis	10.6	DES MB
9	myofibroma	10.5	DES MB
10	bilateral retinoblastoma	10.5	DES MB
11	adenosarcoma	10.5	DES MB
12	pleomorphic rhabdomyosarcoma	10.5	MB MYOD1
13	spindle cell thymoma	10.5	DES MUC1
14	adult fibrosarcoma	10.5	MB MYOD1
15	biphasic synovial sarcoma	10.5	DES MUC1
16	ovarian small cell carcinoma	10.4	DES MUC1
17	infantile myofibromatosis	10.4	DES MB
18	ischemic fasciitis	10.4	DES MUC1
19	desmoplastic small round cell tumor	10.4	DES MUC1
20	proximal spinal muscular atrophy	10.4	DES MUC1
21	uterine sarcoma	10.4	DES MB
22	perivascular epithelioid cell tumor	10.4	DES MUC1
23	reticulum cell sarcoma	10.4	DES MUC1
24	glomangioma	10.4	DES MB
25	dedifferentiated liposarcoma	10.4	DES MUC1
26	extraskeletal ewing sarcoma	10.4	DES MUC1
27	plasmablastic lymphoma	10.4	DES MUC1
28	gliomatosis peritonei	10.4	DES GFAP
29	primitive neuroectodermal tumor of the cervix uteri	10.4	DES GFAP
30	fasciitis	10.3	DES MUC1
31	spindle cell carcinoma	10.3	DES MUC1
32	skeletal muscle cancer	10.3	MB MYOD1
33	pericardial mesothelioma	10.3	MB MUC1
34	muscle tissue disease	10.2	MB MYOD1
35	epithelioid sarcoma	10.2	MB MUC1
36	histiocytoma	10.2	MB MYOD1
37	cavernous hemangioma	10.2	MB MUC1
38	clear cell meningioma	10.2	GFAP MUC1
39	giant cell tumor	10.1	DES MUC1
40	breast rhabdomyosarcoma	10.1	DES MB MYOD1
41	myxofibrosarcoma	10.1	DES S100B
42	botryoid rhabdomyosarcoma	10.1	DES MB MYOD1
43	mesenchymoma	10.1	DES MB MYOD1
44	liposarcoma	10.1	DES MB
45	malignant mesenchymoma	10.1	DES MB MYOD1
46	muscle cancer	10.1	DES MB MYOD1
47	alveolar soft part sarcoma	10.1	DES MB MYOD1
48	rhabdomyosarcoma 2	10.1	DES MB MYOD1
49	juvenile xanthogranuloma	10.1	DES S100B
50	sarcoma, synovial	10.1	DES MUC1

Graphical network of the top 20 diseases related to Spindle Cell Rhabdomyosarcoma:

Sources

Symptoms & Phenotypes for Spindle Cell Rhabdomyosarcoma

Sources

Drugs & Therapeutics for Spindle Cell Rhabdomyosarcoma

Drugs for Spindle Cell Rhabdomyosarcoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 22)

Name

Status

Phase

Clinical Trials

Cas Number

PubChem Id

Cyclophosphamide

Approved, Investigational

Phase 3

50-18-0, 6055-19-2

2907

Synonyms:

(-)-Cyclophosphamide

(+-)-Cyclophosphamide

(RS)-Cyclophosphamide

1-(bis(2-chloroethyl)amino)-1-oxo-2-aza-5-oxaphosphoridine

1-Bis(2-chloroethyl)amino-1-oxo-2-aza-5-oxaphosphoridin

2-[Bis(2-chloroethylamino)]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide

4-Hydroxy-cyclophosphan-mamophosphatide

50-18-0

60007-95-6

6055-19-2 (monohydrate)

75526-90-8

AC1L1EQQ

AI3-26198

Anhydrous cyclophosphamide

Anhydrous, cyclophosphamide

ASTA

Asta B 518

ASTA B518

B 518

B-518

bis(2-Chloroethyl)phosphami de cyclic propanolamide

bis(2-Chloroethyl)phosphamide cyclic propanolamide ester

Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester

BRN 0011744

BSPBio_002099

C 0768

C07888

C7H15Cl2N2O2P

CB 4564

CB-4564

CCRIS 188

CHEBI:4027

CHEMBL32520

CHEMBL88

Ciclofosfamida

Ciclofosfamida [INN-Spanish]

Ciclofosfamide

Ciclophosphamide

Ciclophosphamide [INN]

CID2907

Clafen

Claphene

CPA

CTX

Cycloblastin

Cyclophosphamid

cyclophosphamide

Cyclophosphamide

Cyclophosphamide (anhydrous form)

Cyclophosphamide (anhydrous)

Cyclophosphamide (INN)

Cyclophosphamide (TN)

Cyclophosphamide anhydrous

Cyclophosphamide monohydrate

Cyclophosphamide Monohydrate

Cyclophosphamide Sterile

Cyclophosphamide, (+-)-Isomer

Cyclophosphamide, (R)-isomer

Cyclophosphamide, (S)-isomer

Cyclophosphamides

Cyclophosphamidum

Cyclophosphamidum [INN-Latin]

Cyclophosphan

Cyclophosphane

Cyclophosphanum

Cyclophosphoramide

Cyclostin

Cyklofosfamid

Cyklofosfamid [Czech]

Cytophosphan

Cytophosphane

Cytoxan

Cytoxan (TN)

Cytoxan Lyoph

D,L-Cyclophosphamide

D07760

DB00531

DivK1c_000246

EINECS 200-015-4

Endoxan

Endoxan R

Endoxana

Endoxanal

Endoxan-Asta

Endoxane

Enduxan

EU-0100238

Genoxal

Hexadrin

HMS2090A12

HSDB 3047

IDI1_000246

KBio1_000246

KBio2_001338

KBio2_003906

KBio2_006474

KBio3_001319

KBioGR_000888

KBioSS_001338

Ledoxina

Lopac0_000238

Lopac-C-0768

LS-1302

LS-99787

Lyophilized Cytoxan

Mitoxan

MolPort-001-783-420

Monohydrate, cyclophosphamide

N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide

N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide

NCGC00015209-01

NCGC00015209-03

NCGC00015209-06

NCGC00091741-02

NCGC00091741-03

NCI60_002097

NCI-C04900

Neosar

NINDS_000246

NSC 26271

NSC26271

NSC-26271

NSC273033

NSC273034

Occupation, cyclophosphamide exposure

Procytox

RCRA waste no. U058

Rcra waste number U058

Rcra Waste Number U058

Revimmune

S1217_Selleck

Semdoxan

Sendoxan

Senduxan

SK 20501

SPBio_001071

Spectrum_000858

Spectrum2_001146

Spectrum3_000370

Spectrum4_000304

Spectrum5_000795

STK177249

STOCK2S-91217

UNII-6UXW23996M

WLN: T6MPOTJ BO BN2G2G

Zyklophosphamid

Zyklophosphamid [German]

Dactinomycin

Approved, Investigational

Phase 3

50-76-0

2019 457193

Synonyms:

(- )-actinomycin d

(-)-actinomycin d

01815_FLUKA

1H-Pyrrolo(2,1-1)-(1,4,7,10,13)oxatetraazacyclohexadecine

2-amino-N,N'-bis(hexadecahydro-2,5,9-trimethyl-6,13-bis(1-methylethyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo(2,1-i)(1,4,7,10,13)oxatetra-azacyclohexadecin-10-yl)-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide

2-amino-N,N'-bis(hexadecahydro-2,5,9-trimethyl-6,13-bis(1-methylethyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo(2,1-I)(1,4,7,10,13)oxatetra-azacyclohexadecin-10-yl)-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide

4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide

50-76-0

A1410_SIGMA

A4262_SIGMA

A9415_SIGMA

AC1L1CQX

AC1L9W52

Ac-de

ACon0_000471

ACon1_001004

ACT

ACT D

Actactinomycin a Iv

Actactinomycin A IV

actd

ActD

Actinomycin

Actinomycin 11 cosmegen

Actinomycin 11 Cosmegen

Actinomycin 7

Actinomycin A IV

Actinomycin Aiv

Actinomycin C (sub1)

Actinomycin C(sub1)

Actinomycin C1

actinomycin cl

actinomycin D

Actinomycin D

ACTINOMYCIN D

ACTINOMYCIN D AMP

Actinomycin D (JP15)

Actinomycin D deriv. of 3H-phenoxaocardazine

Actinomycin D, sodium deoxyribonucleic acid complex

Actinomycin I

Actinomycin I (sub1)

Actinomycin I(sub 1)

Actinomycin I(sub1)

Actinomycin I1

Actinomycin iv

Actinomycin Iv

Actinomycin IV

Actinomycin X 1

actinomycin x i

Actinomycin X1

Actinomycin-(threo-val-pro-sar-meval)

Actinomycin-?IV

Actinomycin-[threo-val-pro-sar-meval]

ACTINOMYCIN-D

Actinomycindioic D acid, dilactone

Actinomycindioic D Acid, Dilactone

actinomyein-theo-val-pro-sar-meval

Acto-D

ACTO-D

AD (VAN)

AI3-26374

Antibiotic from Streptomyces parvullus

Antibiotic From Streptomyces Parvullus

BCBcMAP01_000155

Bio1_000342

Bio1_000831

Bio1_001320

BRD-A42383464-001-02-2

C06770

C62H86N12O16

CBiol_002056

CCRIS 9

CHEBI:123721

CHEBI:27666

CHEMBL1554

CHEMBL427947

Chounghwamycin B

CID2019

CID457193

Cosmegen

COSMEGEN (TN)

Cosmegen lyovac

CPD000469227

D Actinomycin

D00214

Dactinomicina

Dactinomicina [INN-Spanish]

Dactinomycin

DACTINOMYCIN

Dactinomycin (USP)

Dactinomycin [USAN:BAN]

Dactinomycin D

Dactinomycine

Dactinomycine [INN-French]

Dactinomycinum

Dactinomycinum [INN-Latin]

dactinomyein d

DB00970

Dilactone actin omycindioic D acid

Dilactone actinomycin D acid

Dilactone Actinomycin D Acid

Dilactone actinomycindioic D acid

Dilactone Actinomycindioic D Acid

DVA-DPR-SAR-MVA-(c1)DTH-PXZ-(c11)DTH-DVA-DPR-SAR-MVA

EINECS 200-063-6

FT-0080366

GNF-PF-1977

HBF 386

HBF 386 meractinomycin

HBF 386 Meractinomycin

HMS2052O17

HSDB 3220

Lemery brand OF dactinomycin

LMPK14000005

LS-142

Lyovac cosmegen

Lyovac Cosmegen

Lyovac, cosmegen

Lyovac-cosmegen

MEGxm0_000350

Meractinomycin

Merck brand OF dactinomycin

Merck frosst brand OF dactinomycin

Merck sharp and dohme brand OF dactinomycin

MLS001424196

MolPort-001-739-741

MolPort-003-925-177

MSD Brand OF dactinomycin

NCGC00025059-02

NCGC00090796-01

NCGC00161622-01

NCGC00161622-02

NCGC00169767-01

NCI60_030539

NCI-C04682

Neuro_000003

NP-005932

NSC 3053

NSC191297

NSC3053

NSC-3053

o)-(1-oxo-1,2-ethanediyl)]bis(N-methyl)L-valine

Oncostatin K

Oxamide

-pentone

PXZ-THR-DVA-PRO-SAR-MVA-THR-DVA-PRO-SAR-MVA

SAM001246846

SMP1_000005

SMR000469227

UNII-1CC1JFE158

UPCMLD-DP055

UPCMLD-DP055:001

UPCMLD-DP055:002

WLN: 16- AN FVN IVN LVO PVM SVTJ G1 J1 KY1&1 N1 RY1&1

X 97

Everolimus

Approved

Phase 3

159351-69-6

6442177

Synonyms:

(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone

(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone

(1R,9S,12S,15R,16E,23S,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriacont

(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34as)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethy

(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone

(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone

001, RAD

07741_FLUKA

159351-69-6

40-O-(2-hydroxyethyl)-rapamycin

40-O-(2-Hydroxyethyl)-rapamycin

42-O-(2-Hydroxyethyl)rapamycin

Afinitor

Certican

CERTICAN(R)

CHEMBL1201755

D02714

DB01590

everolimus

Everolimus

Everolimus (JAN/USAN/INN)

Everolimus [USAN]

LS-143292

MolPort-003-847-342

MolPort-003-925-588

NCGC00167512-01

NVP-RAD-001

RAD 001

RAD, SDZ

RAD001

RAD-001

RAD001, SDZ-RAD, Certican, Zortress, Afinitor, Everolimus

RAD-001C

S1120_Selleck

SDZ RAD

SDZ-RAD

UNII-9HW64Q8G6G

Zortress

Irinotecan

Approved, Investigational

Phase 3

97682-44-5, 100286-90-6

60838

Synonyms:

(+)-Irinotecan

(4S)-4,11-DIETHYL-4-HYDROXY-3,14-DIOXO-3,4,12,14-TETRAHYDRO-1H-PYRANO[3',4':6,7]INDOLIZINO[1,2-B]QUINOLIN-9-YL 1,4'-BIPIPERIDINE-1'-CARBOXYLATE

(4S)-4,11-Diethyl-4-hydroxy-3,14-dioxo-4,12-dihydro-1H-pyrano[3,4-f]quinolino[2,3-a]indolizin-9-yl 4-piperidylpiperidinecarboxylate

1u65

7-Ethyl-10-hydroxycamptothecin

97682-44-5

AC1L1U0Z

AC1Q6PGI

AC-7469

Bio-0054

Biotecan

Biotecan (TN)

BRD-K08547377-003-02-4

BSPBio_002346

C16641

C33H38N4O6

Campothecin-11

Campto

Camptosar

Camptosar, Campto, CPT-11, Irinotecan

Camptothecin-11

CHEBI:105985

CHEMBL481

CID60838

CP0

CPT 11

CPT-11

D08086

DB00762

FT-0083650

HSDB 7607

Irinophore C

irinotecan

Irinotecan (INN)

Irinotecan [INN:BAN]

Irinotecan Hcl

Irinotecan hydrochloride

Irinotecan Hydrochloride

Irinotecan hydrochloride trihydrate

Irinotecan Hydrochloride Trihydrate

IRINOTECAN HYDROCHLORIDE Trihydrate

Irinotecan lactone

Irinotecan mylan

IRINOTECAN, CPT-11

Irinotecanum

Irinotecanum [INN-Latin]

Irrinotecan

LS-44589

NCI60_005051

NK012 Compound

NSC728073

S1198_Selleck

sn 38

sn-38

sn38 CPD

TL8006026

UNII-7673326042

Miconazole

Approved, Investigational, Vet_approved

Phase 3

22916-47-8

4189

Synonyms:

(+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole

1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole

1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole

1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole

1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole

1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole

1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole

1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole

1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole

1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole

22832-87-7 (NITRATE)

22916-47-8

75319-47-0

AB00053500

AC1L1HM1

Aflorix(nitrate)

AKOS001574474

Albistat(nitrate)

Andergin(nitrate)

BPBio1_000279

BRD-A82396632-001-03-0

BRD-A82396632-008-02-7

Brentan

BRN 0965511

BSPBio_000253

BSPBio_002033

CCRIS 7924

CHEBI:6923

CHEMBL91

CID4189

Conofite(nitrate)

CPD-4501

D00416

Dactarin

Daktarin iv

Daktarin IV

DB01110

DivK1c_000156

EINECS 245-324-5

Epi-Monistat(nitrate)

Esteve brand OF miconazole

Femizol-M

Florid(nitrate)

Gyno-Daktar(nitrate)

HMS1568M15

HMS2090B21

I14-14342

IDI1_000156

imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI)

Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI)

Janssen cilag brand OF miconazole

Janssen-cilag brand OF miconazole

Johnston and johnston brand OF miconazole nitrate

KBio1_000156

KBio2_001445

KBio2_004013

KBio2_006581

KBio3_001533

KBioGR_000581

KBioSS_001445

Lotrimin AF(nitrate)

LS-78378

MCZ

Micantin (nitrate)

Miconasil nitrate

Miconasil Nitrate

Miconazol

Miconazol [INN-Spanish]

miconazole

Miconazole

Miconazole (JP15/USP/INN)

Miconazole [USAN:BAN:INN:JAN]

Miconazole 3

Miconazole 3 Combination Pack

Miconazole 7 Combination Pack

Miconazole esteve brand

Miconazole janssen-cilag brand

Miconazole nitrate

Miconazole nitrate salt

Miconazole-7

Miconazolo

Miconazolo [DCIT]

Miconazolum

Miconazolum [INN-Latin]

Micozole

Minostate

MJR 1762

MLS002222203

MolPort-002-557-553

Monazole 7

Monista (nitrate)

Monistat

Monistat (TN)

Monistat 1 Combination Pack

Monistat 3 Dual-Pak

Monistat 3 Vaginal Ovules

Monistat 5 Tampon

Monistat 7 Dual-Pak

Monistat 7 Vaginal Suppositories

Monistat Dual- PAK

Monistat IV

Monistat iv (tn)

Monistat iv (TN)

Monistat-Derm

NCI60_001353

NCI60_001380

NINDS_000156

Nitrate, miconasil

Nitrate, miconazole

Novo-Miconazole Vaginal Ovules

NSC 170986

NSC169434

NSC170986

Oprea1_091955

Prestwick_335

Prestwick0_000067

Prestwick1_000067

Prestwick2_000067

Prestwick3_000067

R 18134

R-14,889

SMR001307249

SPBio_000976

SPBio_002174

Spectrum_000965

Spectrum2_001048

Spectrum3_000507

Spectrum4_000061

Spectrum5_001297

STK834405

STOCK1S-93556

UNII-7NNO0D7S5M

Vusion

Zimycan

Morphine

Approved, Investigational

Phase 3

57-27-2

5288826

Synonyms:

(-)(5.alpha.,6.alpha.)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol

(-)-Heroin hydrochloride

(−)-morphine

(-)-Morphine

(-)Morphine sulfate

(5a,6a)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol

(5a,6a)-didehydro-4,5-Epoxy-17-methylmorphinan-3,6-diol

(5alpha,6alpha)-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol

(5alpha,6alpha)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol

(5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol

(5alpha,6alpha)-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol

(5alpha,6alpha)-didehydro-4,5-Epoxy-17-methylmorphinan-3,6-diol

(5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol

(5R,6S,9R,13S,14R)-4,5-epoxy-N-methyl-7-morphinen-3,6-diol

(5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol

(5α,6α)-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol

(5α,6α)-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol

(7R,7AS,12bs)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol

(7R,7AS,12BS)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol

(7R,7AS,12BS)-3-METHYL-2,3,4,4A,7,7A-HEXAHYDRO-1H-4,12-METHANO[1]BENZOFURO[3,2-E]ISOQUINOLINE-7,9-DIOL

17-methyl-7,8-didehydro-4,5alpha-epoxymorphinan-3,6alpha-diol

4,5alpha-Epoxy-17-methyl-7-morphinen-3,6alpha-diol

47106-99-0

4-methyl-(13R,14S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol

57-27-2

6211-15-0 (sulfate (2:1) (salt) pentahydrate)

64-31-3

64-31-3 (sulfate (2:1) (salt) anhydrous)

7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol

7,8-Didehydro-4,5-epoxy-17-methyl-morphinan-3,6-diol

8053-16-5

85201-37-2

anhydrous morphine

Apokyn

Astramorph PF

Avinza

BIDD:GT0147

C01516

CCRIS 5762

CHEBI:17303

CHEMBL70

Chloride, morphine

CID5288826

Contin, MS

Cube juice

D-(-)-Morphine

DB00295

DEA No. 9300

Depodur

DepoDur

Diacetylmorphine hydrochloride

Diamorphine hydrochloride

Dolcontin

Dreamer

Dulcontin

Duramorph

Duramorph PF

Duromorph

EINECS 200-320-2

Epimorph

Hard stuff

Heroin hydrochloride

Heroine hydrochloride

Hocus

HSDB 2134

Infumorph

Kadian

l-Morphine

LS-91748

M.O.S

Meconium

M-Eslon

MOI

MolPort-003-849-273

morfina

Morfina

Morfina [Italian]

Morphia

Morphin

Morphin [German]

Morphina

Morphina [Italian]

morphine

Morphine [BAN]

Morphine chloride

Morphine Extra-Forte

Morphine Forte

Morphine H.P

Morphine sulfate

Morphine Sulfate

MORPHINE SULFATE

Morphine sulfate (2:1), anhydrous

Morphine sulfate (2:1), pentahydrate

MORPHINE, (5A,6A)-7,8-DIDEHYDRO-4,5-EPOXY-17-METHYLMORPHINIAN-3,6-DIOL, MORPHIUM, MORPHIA, DOLCONTIN, DUROMORPH, MORPHINA, NEPENTHE

Morphinism

Morphinum

Morphitec

Morphium

Morpho

Moscontin

Ms Contin

MS Contin

Ms Emma

MS/L

MS/S

MSIR

nchembio.317-comp1

nchembio.64-comp1

Nepenthe

NSC11441

O,O'-Diacetylmorphine hydrochloride

OMS Concentrate

Oramorph SR

Ospalivina

Rescudose

RMS

RMS Uniserts

Roxanol

Roxanol 100

Roxanol UD

SDZ 202-250

SDZ202-250

Statex

Statex Drops

Statex SR

Sulfate, morphine

UNII-76I7G6D29C

Unkie

Sirolimus

Approved, Investigational

Phase 3

53123-88-9

5284616 6436030 46835353

Synonyms:

(-)-rapamycin

(-)-Rapamycin

1fkb

1pbk

23,27-Epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine

23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine

23,27-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29

3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone

53123-88-9

A422989, NSC226080

AC1L1JH9

AC1L7MJ9

AC1L9ZMV

AC-722

Ambotz53123-88-9

Antibiotic AY 22989

AY 22989

AY22989

AY-22989

BIDD:PXR0165

Bio1_000293

Bio1_000782

Bio1_001271

Bio2_000375

Bio2_000855

BiomolKI2_000084

C07909

C51H79NO13

CBiol_002007

CCRIS 9024

CHEBI:100923

CHEBI:9168

CHEMBL413

CID10213190

CID10795871

CID11949238

CID11959112

CID313006

CID478951

CID5040

CID5284616

CID5358081

CID5374464

CID5460439

CID5497196

CID5924240

CID6436030

CID6610270

CID6610346

CID6711160

CID6713081

CID9833581

CID9854379

CID9854380

CID9962926

CID9962928

D00753

DB00877

DE-109

DivK1c_006936

FT-0082351

heptadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy

HMS2089A21

HSDB 7284

KBio1_001880

KBio2_000410

KBio2_002978

KBio2_005546

KBio3_000779

KBio3_000780

KBioGR_000410

KBioSS_000410

LCP-Siro

LMPK06000003

LS-143290

MLS000028373

MolMap_000043

MolPort-003-959-433

MS-R001

NCGC00021305-05

nchembio.100-comp4

nchembio.2007.42-comp2

nchembio.79-comp1

nchembio762-comp1

nchembio883-comp3

NCI60_001851

NCIMech_000355

NSC 226080

NSC226080

Perceiva

QTL1_000069

R0395_SIAL

R0395_SIGMA

RAP

RAPA

Rapammune

Rapamune

Rapamune (TN)

rapamycin

Rapamycin

Rapamycin (TN)

Rapamycin C-7, analog 4

Rapamycin from Streptomyces hygroscopicus

Rapamycin Immunosuppressant Drug

RPM

S1039_Selleck

SIIA 9268A

SILA 9268A

SILA9268A

sirolimus

Sirolimus

sirolimús

Sirolimus (RAPAMUNE)

Sirolimus (USAN/INN)

Sirolimus [USAN:BAN:INN]

Sirolimus, Rapamune,Rapamycin

sirolimusum

SMP1_000255

SMR000058564

SpecPlus_000840

UNII-W36ZG6FT64

UNM-0000358684

Wy 090217

WY-090217

Vincristine

Approved, Investigational

Phase 3

2068-78-2, 57-22-7

5978

Synonyms:

22-Oxovincaleukoblastin

22-Oxovincaleukoblastine

28379-27-3

57-22-7

AC1L1LJC

C07204

C46H56N4O10

CCRIS 5763

Cellcristin

CHEBI:28445

CID5978

Citomid

D08679

DB00541

EINECS 200-318-1

Farmistin

HMS2090E19

HSDB 3199

Indole alkaloid

LCR

Leurocristine

Lilly 37231 (1:1 sulfate salt)

Liposomal Vincristine

LS-228

Marqibo

NCGC00163700-01

NCI60_026703

NCI-C04864

NSC-67574

Onco TCS

Oncovin

Oncovin (1:1 sulfate salt)

Oncovine

Onkocristin

PFS, Vincasar

Sulfate, vincristine

Tecnocris

Tecnocris (TN)

UNII-5J49Q6B70F

VCR

VIN

Vincaleukoblastine, 22-oxo- 22-Oxovincaleukoblastine

Vincasar

Vincasar (1:1 sulfate salt)

Vincasar PFS

Vincrex

Vincrex (1:1 sulfate salt)

Vincristin

Vincristin bristol

Vincristin medac

Vincristina

Vincristina [DCIT]

vincristine

Vincristine (INN)

Vincristine [INN:BAN]

Vincristine sulfate

Vincristine Sulfate

Vincristine Sulfate PFS

Vincristinum

Vincristinum [INN-Latin]

Vincrisul

Vincrstine

Vincrystine

Vinkristin

Vintec

Z-D-Val-lys(Z)-OH

Z-D-Val-Lys(Z)-OH

Camptothecin

Experimental

Phase 3

7689-03-4

Alkylating Agents

Phase 3

Anti-Bacterial Agents

Phase 3

Antibiotics, Antitubercular

Phase 3

Antifungal Agents

Phase 3

Anti-Infective Agents

Phase 3

Antimitotic Agents

Phase 3

Antineoplastic Agents, Alkylating

Phase 3

Antineoplastic Agents, Phytogenic

Phase 3

Antirheumatic Agents

Phase 3

Immunosuppressive Agents

Phase 3

Nucleic Acid Synthesis Inhibitors

Phase 3

topoisomerase I inhibitors

Phase 3

Topoisomerase Inhibitors

Phase 3

Interventional clinical trials:

#	Name	Status	NCT ID	Phase	Drugs
1	Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma	Recruiting	NCT02567435	Phase 3	Cyclophosphamide;Irinotecan Hydrochloride;Temsirolimus;Vincristine Sulfate
2	Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma	Active, not recruiting	NCT00075582	Phase 3	dactinomycin;cyclophosphamide;vincristine sulfate

Search NIH Clinical Center for Spindle Cell Rhabdomyosarcoma

Sources

Genetic Tests for Spindle Cell Rhabdomyosarcoma

Sources

Anatomical Context for Spindle Cell Rhabdomyosarcoma

MalaCards organs/tissues related to Spindle Cell Rhabdomyosarcoma:

⁴¹

Tongue, Prostate, Bone

Sources

Publications for Spindle Cell Rhabdomyosarcoma

Articles related to Spindle Cell Rhabdomyosarcoma:

(show all 34)

#	Title	Authors	Year
1	Spindle cell rhabdomyosarcoma of bone with FUS-TFCP2 fusion: confirmation of a very recently described rhabdomyosarcoma subtype. ( 29758589 )	Dashti N.K....Folpe A.L.	2018
2	Spindle cell rhabdomyosarcoma of the anterior mandible manifesting as a periapical lesion of pulpal origin: Case report. ( 29665230 )	Sadhasivam V....Doss D.M.	2018
3	Lumbar Intraspinal Spindle Cell Rhabdomyosarcoma as a Rare Cause of Spinal Stenosis: A Case Report. ( 29452297 )	Sequea D.A....Reese M.E.	2018
4	Spindle-cell rhabdomyosarcoma of the thumb: Rare site, rare tumor in a child. ( 27502215 )	Mahana S....Gupta R.	2016
5	Paratesticular Spindle Cell Rhabdomyosarcoma. ( 26500726 )	Dey B....Chander J.	2015
6	An adult spindle cell rhabdomyosarcoma in the head and neck region with long-term survival: a case report. ( 24946859 )	Hartmann S....MA1ller-Richter U.D.	2014
7	Spindle cell rhabdomyosarcoma of the retroperitoneum: an unusual case developed in a pregnant woman but obscured by pregnancy. ( 25197361 )	Yu L....Yang S.J.	2014
8	Recurrent MYOD1 mutations in pediatric and adult sclerosing and spindle cell rhabdomyosarcomas: evidence for a common pathogenesis. ( 24824843 )	Agaram N.P....Antonescu C.R.	2014
9	Spindle cell rhabdomyosarcoma in the hypopharynx of an adult. ( 25197406 )	Wu T.T....Zheng Z.J.	2014
10	An Adult Case of Paratesticular Spindle Cell Rhabdomyosarcoma. ( 26839788 )	Delto J.C....Nieder A.M.	2014
11	Transactivating mutation of the MYOD1 gene is a frequent event in adult spindle cell rhabdomyosarcoma. ( 24272621 )	Szuhai K....Hogendoorn P.C.	2014
12	Spindle cell rhabdomyosarcoma of the neck with t(6;8) translocation: report of a case and literature review. ( 23113671 )	Mentrikoski M.J....LeGallo R.	2013
13	Spindle cell rhabdomyosarcoma displaying CD34 positivity: a potential diagnostic pitfall; report of two pediatric cases. ( 24022313 )	KaAsar A....DervA+A9oA9lu S.	2013
14	Spindle cell rhabdomyosarcoma: a brief diagnostic review and differential diagnosis. ( 23899074 )	Carroll S.J....Nodit L.	2013
15	Recurrent NCOA2 gene rearrangements in congenital/infantile spindle cell rhabdomyosarcoma. ( 23463663 )	Mosquera J.M....Antonescu C.R.	2013
16	Spindle cell rhabdomyosarcoma of the prostate. ( 23320845 )	Latz S....Fechner G.	2013
17	Exfoliative cytologic findings of maxillary sinus spindle cell rhabdomyosarcoma. ( 20518428 )	Daneshbod Y....Khademi B.	2010
18	Aggressive spindle cell rhabdomyosarcoma in an 11-month-old boxer dog. ( 20460837 )	da Roza M.R....Miguel M.C.	2010
19	Sclerosing spindle cell rhabdomyosarcoma in an adult: report of a new case and review of the literature. ( 19017660 )	Gavino A.C....Peng Y.	2010
20	Unique case of giant adult paratesticular spindle cell rhabdomyosarcoma. ( 19036416 )	Silvestris N....Colucci G.	2009
21	[Clinicopathologic analysis of spindle cell rhabdomyosarcoma: report of 8 cases]. ( 18646700 )	Zhang H.T....Su Q.	2008
22	Radiation-induced mandibular adult spindle cell rhabdomyosarcoma. ( 18023143 )	Goosens V....Casselman J.	2008
23	Spindle cell rhabdomyosarcoma in adults: clinicopathological and immunohistochemical analysis of seven new cases. ( 17013628 )	Mentzel T....Kuhnen C.	2006
24	Kit expression in spindle cell rhabdomyosarcoma can possibly create a different approach for its tumorigenesis and therapy. ( 16860492 )	Diniz G....Vergin C.	2006
25	Spindle cell rhabdomyosarcoma in adults. ( 16006807 )	Nascimento A.F....Fletcher C.D.	2005
26	Paratesticular spindle cell rhabdomyosarcoma diagnosed by fine needle aspiration cytology: a case report. ( 15966299 )	Daneshbod Y....Rastegar M.	2005
27	Spindle cell rhabdomyosarcoma of the tongue in an infant: a case report with emphasis on differential diagnosis of childhood spindle cell lesions. ( 15462501 )	Gupta A....Chou P.M.	2004
28	Spindle-cell rhabdomyosarcoma with 2q36 approximately q37 involvement. ( 12550761 )	Debiec-Rychter M....Sciot R.	2003
29	Paratesticular spindle cell rhabdomyosarcoma in an adult. ( 11458081 )	Kizer W.S....Schwartz B.F.	2001
30	Spindle cell rhabdomyosarcoma in adults. A case report and literature review. ( 10674275 )	Fernando Val-Bernal J....GA^mez-RomA!n J.J.	2000
31	Cytogenetic study of a spindle-cell rhabdomyosarcoma of the parotid gland. ( 10087951 )	Gil-Benso R....Llombart-Bosch A.	1999
32	Spindle cell rhabdomyosarcoma (so-called) in adults: report of two cases with emphasis on differential diagnosis. ( 9537474 )	Rubin B.P....Fletcher C.D.	1998
33	Spindle cell rhabdomyosarcoma: histologic variant of embryonal rhabdomyosarcoma with association to favorable prognosis. ( 7882713 )	Leuschner I.	1995
34	Spindle cell rhabdomyosarcoma. A prognostically favorable variant of rhabdomyosarcoma. ( 1599014 )	Cavazzana A.O....Salviati G.	1992

Sources

Genes for Spindle Cell Rhabdomyosarcoma

Genes related to Spindle Cell Rhabdomyosarcoma (0 elite genes):

- Elite gene

- Cancer Census gene in COSMIC

#	Symbol	Description	Category	Score	Evidence
1	MYOD1	Myogenic Differentiation 1	Protein Coding	24.66	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)
2	NCOA2	Nuclear Receptor Coactivator 2	Protein Coding	22.89	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)
3	MB	Myoglobin	Protein Coding	22.82	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)
4	DES	Desmin	Protein Coding	17.56	GeneCards inferred via : Publications (show sections)
5	GFAP	Glial Fibrillary Acidic Protein	Protein Coding	16.86	GeneCards inferred via : Publications (show sections)
6	S100B	S100 Calcium Binding Protein B	Protein Coding	16.86	GeneCards inferred via : Publications (show sections)
7	MUC1	Mucin 1, Cell Surface Associated	Protein Coding	16.86	GeneCards inferred via : Publications (show sections)

Sources

Variations for Spindle Cell Rhabdomyosarcoma

Cosmic variations for Spindle Cell Rhabdomyosarcoma:

⁹

(show top 50) (show all 112)

#	Cosmic Mut ID	Gene Symbol	COSMIC Disease Classification (Primary site, Site subtype, Primary histology, Histology subtype)	Mutation CDS	Mutation AA	GRCh38 Location	Conf
1	COSM45005	TP53	soft tissue,NS,rhabdomyosarcoma,embryonal	c.739A>G	p.N247D	17:7674224-7674224	5
2	COSM11081	TP53	soft tissue,NS,rhabdomyosarcoma,embryonal	c.733G>T	p.G245C	17:7674230-7674230	5
3	COSM10662	TP53	soft tissue,NS,rhabdomyosarcoma,embryonal	c.743G>A	p.R248Q	17:7674220-7674220	5
4	COSM10654	TP53	soft tissue,NS,rhabdomyosarcoma,embryonal	c.637C>T	p.R213*	17:7674894-7674894	5
5	COSM44720	TP53	soft tissue,NS,rhabdomyosarcoma,embryonal	c.961A>T	p.K321*	17:7673567-7673567	5
6	COSM6932	TP53	soft tissue,NS,rhabdomyosarcoma,embryonal	c.733G>A	p.G245S	17:7674230-7674230	5
7	COSM45255	TP53	soft tissue,NS,rhabdomyosarcoma,embryonal	c.668C>G	p.P223R	17:7674863-7674863	5
8	COSM6986214	SOX9	soft tissue,NS,rhabdomyosarcoma,embryonal	c.76A>G	p.M26V	17:72121467-72121467	5
9	COSM6986215	PTPRT	soft tissue,NS,rhabdomyosarcoma,embryonal	c.2277G>T	p.Q759H	20:42248779-42248779	5
10	COSM13016	PTPN11	soft tissue,NS,rhabdomyosarcoma,embryonal	c.226G>C	p.E76Q	12:112450406-112450406	5
11	COSM14271	PTPN11	soft tissue,NS,rhabdomyosarcoma,embryonal	c.1508G>T	p.G503V	12:112489084-112489084	5
12	COSM13014	PTPN11	soft tissue,NS,rhabdomyosarcoma,embryonal	c.214G>A	p.A72T	12:112450394-112450394	5
13	COSM13013	PTPN11	soft tissue,NS,rhabdomyosarcoma,embryonal	c.205G>A	p.E69K	12:112450385-112450385	5
14	COSM6986208	PTCH1	soft tissue,NS,rhabdomyosarcoma,embryonal	c.208G>A	p.A70T	9:95506593-95506593	5
15	COSM6910708	POLE	soft tissue,NS,rhabdomyosarcoma,embryonal	c.5975G>C	p.C1992S	12:132634215-132634215	5
16	COSM1083818	PIK3CG	soft tissue,NS,rhabdomyosarcoma,embryonal	c.2638G>A	p.E880K	7:106883041-106883041	5
17	COSM763	PIK3CA	soft tissue,NS,rhabdomyosarcoma,embryonal	c.1633G>A	p.E545K	3:179218303-179218303	5
18	COSM775	PIK3CA	soft tissue,NS,rhabdomyosarcoma,embryonal	c.3140A>G	p.H1047R	3:179234297-179234297	5
19	COSM760	PIK3CA	soft tissue,NS,rhabdomyosarcoma,embryonal	c.1624G>A	p.E542K	3:179218294-179218294	5
20	COSM6914067	PDGFRA	soft tissue,NS,rhabdomyosarcoma,embryonal	c.3195G>C	p.E1065D	4:54295197-54295197	5
21	COSM6964921	NTRK3	soft tissue,NS,rhabdomyosarcoma,embryonal	c.492C>A	p.C164*	15:88137534-88137534	5
22	COSM580	NRAS	soft tissue,NS,rhabdomyosarcoma,embryonal	c.181C>A	p.Q61K	1:114713909-114713909	5
23	COSM585	NRAS	soft tissue,NS,rhabdomyosarcoma,embryonal	c.183A>T	p.Q61H	1:114713907-114713907	5
24	COSM564	NRAS	soft tissue,NS,rhabdomyosarcoma,embryonal	c.35G>A	p.G12D	1:114716126-114716126	5
25	COSM569	NRAS	soft tissue,NS,rhabdomyosarcoma,embryonal	c.37G>C	p.G13R	1:114716124-114716124	5
26	COSM584	NRAS	soft tissue,NS,rhabdomyosarcoma,embryonal	c.182A>G	p.Q61R	1:114713908-114713908	5
27	COSM563	NRAS	soft tissue,NS,rhabdomyosarcoma,embryonal	c.34G>A	p.G12S	1:114716127-114716127	5
28	COSM574	NRAS	soft tissue,NS,rhabdomyosarcoma,embryonal	c.38G>T	p.G13V	1:114716123-114716123	5
29	COSM562	NRAS	soft tissue,NS,rhabdomyosarcoma,embryonal	c.34G>T	p.G12C	1:114716127-114716127	5
30	COSM6910706	NOTCH1	soft tissue,NS,rhabdomyosarcoma,embryonal	c.3277T>C	p.Y1093H	9:136508280-136508280	5
31	COSM6933086	NF1	soft tissue,NS,rhabdomyosarcoma,embryonal	c.7870G>C	p.A2624P	17:31357269-31357269	5
32	COSM1745010	MYOD1	soft tissue,NS,rhabdomyosarcoma,embryonal	c.365T>G	p.L122R	11:17720147-17720147	5
33	COSM516	KRAS	soft tissue,NS,rhabdomyosarcoma,embryonal	c.34G>T	p.G12C	12:25245351-25245351	5
34	COSM521	KRAS	soft tissue,NS,rhabdomyosarcoma,embryonal	c.35G>A	p.G12D	12:25245350-25245350	5
35	COSM532	KRAS	soft tissue,NS,rhabdomyosarcoma,embryonal	c.38G>A	p.G13D	12:25245347-25245347	5
36	COSM522	KRAS	soft tissue,NS,rhabdomyosarcoma,embryonal	c.35G>C	p.G12A	12:25245350-25245350	5
37	COSM553	KRAS	soft tissue,NS,rhabdomyosarcoma,embryonal	c.182A>T	p.Q61L	12:25227342-25227342	5
38	COSM6930430	KMT2D	soft tissue,NS,rhabdomyosarcoma,embryonal	c.1291G>T	p.E431*	12:49052392-49052392	5
39	COSM2965310	KDM6A	soft tissue,NS,rhabdomyosarcoma,embryonal	c.493C>T	p.R165*	23:45020659-45020659	5
40	COSM486	HRAS	soft tissue,NS,rhabdomyosarcoma,embryonal	c.37G>C	p.G13R	11:534286-534286	5
41	COSM480	HRAS	soft tissue,NS,rhabdomyosarcoma,embryonal	c.34G>A	p.G12S	11:534289-534289	5
42	COSM496	HRAS	soft tissue,NS,rhabdomyosarcoma,embryonal	c.181C>A	p.Q61K	11:533875-533875	5
43	COSM483	HRAS	soft tissue,NS,rhabdomyosarcoma,embryonal	c.35G>T	p.G12V	11:534288-534288	5
44	COSM481	HRAS	soft tissue,NS,rhabdomyosarcoma,embryonal	c.34G>T	p.G12C	11:534289-534289	5
45	COSM5702570	FGFR1	soft tissue,NS,rhabdomyosarcoma,embryonal	c.1611G>T	p.M537I	8:38417358-38417358	5
46	COSM1251469	ERCC5	soft tissue,NS,rhabdomyosarcoma,embryonal	c.3256G>A	p.G1086R	13:102875598-102875598	5
47	COSM959251	DICER1	soft tissue,NS,rhabdomyosarcoma,embryonal	c.5113G>A	p.E1705K	14:95094139-95094139	5
48	COSM3744763	DICER1	soft tissue,NS,rhabdomyosarcoma,embryonal	c.5428G>T	p.D1810Y	14:95091302-95091302	5
49	COSM3738451	DICER1	soft tissue,NS,rhabdomyosarcoma,embryonal	c.5439G>T	p.E1813D	14:95091291-95091291	5
50	COSM3738549	DICER1	soft tissue,NS,rhabdomyosarcoma,embryonal	c.5365-1G>T	p.?	14:95091366-95091366	5

Sources

Expression for Spindle Cell Rhabdomyosarcoma

Search GEO for disease gene expression data for Spindle Cell Rhabdomyosarcoma.

Sources

Pathways for Spindle Cell Rhabdomyosarcoma

Pathways related to Spindle Cell Rhabdomyosarcoma according to GeneCards Suite gene sharing:

#	Super pathways	Score	Top Affiliating Genes
1	Neural Stem Cell Differentiation Pathways and Lineage-specific Markers ⁶⁵	10.85	GFAP S100B
2	Regulation of nuclear SMAD2/3 signaling ¹	10.51	MYOD1 NCOA2

Sources

GO Terms for Spindle Cell Rhabdomyosarcoma

Cellular components related to Spindle Cell Rhabdomyosarcoma according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	intermediate filament cytoskeleton	GO:0045111	8.62	DES GFAP

Biological processes related to Spindle Cell Rhabdomyosarcoma according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	long-term synaptic potentiation	GO:0060291	8.96	GFAP S100B
2	intermediate filament organization	GO:0045109	8.62	DES GFAP

Molecular functions related to Spindle Cell Rhabdomyosarcoma according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	RNA polymerase II proximal promoter sequence-specific DNA binding	GO:0000978	9.13	MUC1 MYOD1 NCOA2
2	nuclear hormone receptor binding	GO:0035257	8.62	MYOD1 NCOA2

Sources

Sources for Spindle Cell Rhabdomyosarcoma

¹ BioSystems

² BitterDB

³ CDC

⁴ Cell Signaling Technology

⁵ ClinicalTrials

⁶ ClinVar

⁷ CNVD

⁸ Cochrane Library

⁹ Cosmic

¹⁰ dbSNP

¹¹ DGIdb

¹² Disease Ontology

¹³ diseasecard

¹⁴ DiseaseEnhancer

¹⁵ DISEASES

¹⁶ DrugBank

¹⁷ ExPASy

¹⁸ FDA Approved Drugs

¹⁹ FMA

²⁰ GeneAnalytics

²¹ GeneCards

²² GeneGo (Thomson Reuters)

²³ GeneHancer via GeneCards

²⁴ GeneReviews

²⁵ Genetics Home Reference

²⁶ GenomeRNAi

²⁷ GEO DataSets

²⁸ GO

²⁹ GTR

³⁰ HGMD

³¹ HMDB

³² HPO

³³ ICD10

³⁴ ICD10 via Orphanet

³⁵ ICD9CM

³⁶ IUPHAR

³⁷ KEGG

³⁸ LifeMap

³⁹ LncRNADisease

⁴⁰ LOVD

⁴¹ MalaCards

⁴² MedGen

⁴³ MedlinePlus

⁴⁴ MeSH

⁴⁵ MESH via Orphanet

⁴⁶ MGI

⁴⁷ miR2Disease

⁴⁸ NCBI Bookshelf

⁴⁹ NCI

⁵⁰ NCIt

⁵¹ NDF-RT

⁵² NIH Clinical Center

⁵³ NIH Rare Diseases

⁵⁴ NINDS

⁵⁵ Novoseek

⁵⁶ Novus Biologicals

⁵⁷ OMIM

⁵⁸ OMIM via Orphanet

⁵⁹ Orphanet

⁶⁰ PathCards

⁶¹ PharmGKB

⁶² PubMed

⁶³ PubMed Health

⁶⁴ QIAGEN

⁶⁵ R&D Systems

⁶⁶ Reactome

⁶⁷ Sino Biological

⁶⁸ SNOMED-CT

⁶⁹ SNOMED-CT via HPO

⁷⁰ SNOMED-CT via Orphanet

⁷¹ TGDB

⁷² Tocris

⁷³ UMLS

⁷⁴ UMLS via Orphanet

⁷⁵ UniProtKB/Swiss-Prot

⁷⁶ Wikipedia